CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale Chief Administrative Officer sold 265 shares at $20.31 ($5,382)
- 4 Open-market sale Chief Financial Officer sold 300 shares at $20.31 ($6,093)
- 4 Open-market sale Chief Legal Officer sold 300 shares at $20.31 ($6,093)
- 4 Open-market sale President, R&D sold 8,999 shares at an average $20.03 ($180,290)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President, R&D sold 14,811 shares at an average $24.74 ($366,367)
- 4 Open-market sale Chief Administrative Officer sold 435 shares at $25.57 ($11,123)
- 4 Open-market sale Chief Financial Officer sold 725 shares at $25.57 ($18,538)
- 4 Open-market sale Chief Legal Officer sold 708 shares at $25.57 ($18,104)
- 4 Open-market sale President and CEO sold 84,000 shares at an average $31.42 ($2,639,280)
- 4 Open-market sale President, R&D sold 18,000 shares at $30.32 ($545,760)
- 4 Open-market sale Chief Administrative Officer sold 294 shares at $29.87 ($8,782)
- 4 Open-market sale Chief Financial Officer sold 282 shares at $29.87 ($8,423)
- 4 Open-market sale President, R&D sold 622 shares at $29.87 ($18,579)
- 4 Open-market sale Chief Legal Officer sold 333 shares at $29.87 ($9,947)
Page 12 of 16 · 320 filings